Investigation of in-vitro Efficacy of Antibiotic Combinations and Presence of Carbapenemases in Multidrug-Resistant Klebsiella pneumoniae Isolates
Jundishapur Journal of Microbiology · 24.02.2026 · 19 (2)
DOI: 10.5812/jjm-169256 ↗Kurz gefasst
Fachartikel in der Zeitschrift Jundishapur Journal of Microbiology, online erschienen am 24.02.2026. Verfasst von Pelin Kamuran Duran Aksoy und 1 weiteren Autor:innen. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Multidrug resistance (MDR) is increasingly being detected in Klebsiella pneumoniae strains. The combined use of antibiotics is one of the important choices in the treatment of these infections.
Objectives
This study aimed to evaluate the in-vitro activity of the binary combinations of colistin (COL), meropenem (MEM), and ceftazidime/avibactam (CZA) against multidrug-resistant K. pneumoniae clinical isolates and to identify carbapenemase genes.
Methods
Between January 2022 and November 2023, randomly selected MDR K. pneumoniae isolates (n = 90) isolated from patient samples were included in the study. All isolates were investigated for carbapenem resistance genes using the PCR method. Additionally, the carbapenem inactivation method (CIM) was used as a phenotypic method to investigate carbapenemase production. Antimicrobial interactions (synergy test) were determined using the checkerboard method.
Results
The most common carbapenem resistance gene was OXA-48 (72 isolates). The KPC gene was detected in 10 isolates, and the NDM gene in 5 isolates. A synergy test was performed on isolates randomly selected from among those resistant to at least one of the antibiotics COL, CZA, and MEM. Synergistic effect was detected in 50% of the COL-CZA combination, 75% of the MEM-CZA combination, and 45% of the MEM-COL combination.
Conclusions
OXA-48 was the most frequently detected carbapenemase gene in MDR K. pneumoniae isolates in our region, and KPC and NDM carbapenemase genes were also detected. The high synergy-partial synergy ratios identified in antibiotics may represent a promising treatment option for infections caused by MDR K. pneumoniae, but this requires confirmation in studies with larger sample sizes.
Zitieren
APA
Aksoy, P. K. D., & Caliskan, E. (2026). Investigation of in-vitro Efficacy of Antibiotic Combinations and Presence of Carbapenemases in Multidrug-Resistant Klebsiella pneumoniae Isolates. Jundishapur Journal of Microbiology, 19(2). https://doi.org/10.5812/jjm-169256
Vancouver
Aksoy PKD, Caliskan E. Investigation of in-vitro Efficacy of Antibiotic Combinations and Presence of Carbapenemases in Multidrug-Resistant Klebsiella pneumoniae Isolates. Jundishapur Journal of Microbiology. 2026;19(2). doi:10.5812/jjm-169256
BibTeX
@article{Aksoy2026,
author = {Aksoy, Pelin Kamuran Duran and Caliskan, Emel},
title = {Investigation of in-vitro Efficacy of Antibiotic Combinations and Presence of Carbapenemases in Multidrug-Resistant Klebsiella pneumoniae Isolates},
journal = {Jundishapur Journal of Microbiology},
year = {2026},
volume = {19},
number = {2},
doi = {10.5812/jjm-169256}
}
EUVIMED